secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspire Biopharma Holdings, Inc. (ASBP)
CIK:        0001847345
Form:       8-K
Filed at:   2023-05-01T23:59:59+00:00
Accession:  0001104659-23-053721
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PowerUp Acquisition enters non-redemption deal to secure 150K shares for extension vote
--------------------------------------------------------------------------------

- Third party agreed not to redeem 150,000 Class A ordinary shares at extraordinary general meeting for extension approval.
- Sponsor will transfer 75,000 Class B ordinary shares to investor after completion of an initial business combination.
- Proposed extension moves deadline from May 23, 2023 to May 23, 2024 for initial business combination.
- Agreement does not increase likelihood of extension approval but retains funds in trust account.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847345/000110465923053721/0001104659-23-053721-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847345/000110465923053721/tm2314231d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-053721

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer